ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
7,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
8,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
8,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
8,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
9,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
9,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
9,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
10,2,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
10,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
10,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
10,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
10,8,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,10,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
11,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
11,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
12,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12,4,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12,5,Headache,Headaches NEC,Headaches,Nerv,N
12,6,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
12,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
12,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
13,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
14,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
16,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
